Potential Costs and Effects of the National Service Framework for Coronary Heart Disease in the UK

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.21, Iss.1, 2003-01, pp. : 49-60

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Improvements in coronary heart disease (CHD) care made through the UK National Health Service's

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 385, 2002-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Costs of a Community Pharmacist-Led Medicines Management Service for Patients with Coronary Heart Disease in England: Healthcare System and Patient Perspectives

By Scott Anthony Tinelli Michela Bond Christine

PharmacoEconomics, Vol. 25, Iss. 5, 2007-01 ,pp. : 397-411

Adis International

Access to resources Recommend Favorite

Costs and Effects of Secondary Prevention with Perindopril in Stable Coronary Heart Disease in Poland: An Analysis of the EUROPA Study Including 1251 Polish Patients

By Redekop W. Ken

PharmacoEconomics, Vol. 26, Iss. 10, 2008-01 ,pp. : 861-877

Adis International

Access to resources Recommend Favorite

Service provision for liver disease in the UK: a national questionnaire-based survey

By Scott R Williams M Lawson A Austin A Freeman J

Clinical Medicine, Vol. 12, Iss. 2, 2012-04 ,pp. : 114-118

Royal College Of Physicians

Access to resources Recommend Favorite

Indirect costs of heart disease

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 263, 2000-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite